12:00 AM
 | 
May 20, 2013
 |  BC Week In Review  |  Company News  |  Other News

Anaptys, U.S. Department of Defense other, antibodies news

AnaptysBio received a contract from the DoD's Defense Threat Reduction Agency (DTRA) to develop highly thermostable anti-ricin antibodies...

Read the full 66 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >